ISN Oceania and South East Asia Regional Board Webinar: Equity in providing dialysis care in South East Asia
Dialysis is the most prevalent form of kidney replacement therapy affecting 2-7 million people worldwide. There is a disproportionate projected growth rate in dialysis requirement mostly in Asia countries. However, dialysis remains a cost-ineffective intervention in terms of health gains per unit of expenditure. Despite that, health systems prioritized dialysis because it serves an identifiable population that would otherwise die. In low-income and lower-middle-income countries (LMICs), dialysis has grown mainly in the private sector and relies on out-of-pocket payment. As a result, most patients who start dialysis in LMICs can only continue for a short time because of the costs. There are large global inequities in access to long-term dialysis more so in LMICs. We shall hear from speakers from three South East Asia countries sharing their experience and lesson learned from their country dialysis program.
- An overview of dialysis program in countries in South East Asia
- To understand the inequity in provision of dialysis in SEA countries
- To learn from previous lesson and experience to improve dialysis provision in SEA region.
- Bringing equity in access to quality dialysis (Valerie A Luyckx, David C H Harris, Cherian Varghese, Vivekanand Jha)
Published:April 15, 2021DOI: https://doi.org/10.1016/S0140-6736(21)00732-7
- Liyanage T Ninomiya T Jha V et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015; 385: 1975-1982
- GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020; 395: 709-733